Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants
Main Authors: | Eli Fritz McDonald, Kathryn E. Oliver, Jonathan P. Schlebach, Jens Meiler, Lars Plate |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810519/?tool=EBI |
Similar Items
-
Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants.
by: Eli Fritz McDonald, et al.
Published: (2024-01-01) -
P617: Is it time to switch to AlphaMissense for in silico missense predictions?
by: Shruthi Mohan, et al.
Published: (2024-01-01) -
P641: Application of AlphaMissense prediction to pathogenicity classification of missense variants from clinical exome sequencing
by: Xinming Zhuo, et al.
Published: (2024-01-01) -
Predicting valuable missense variants with AlphaMissense in a multiple pulmonary infection patient
by: Tianyuan Wang, et al.
Published: (2024-02-01) -
AlphaMissense, a groundbreaking advancement in artificial intelligence for predicting the effects of missense variants
by: Ming Yi, et al.
Published: (2024-03-01)